(Reuters) – President Vladimir Putin stated on Tuesday that certain medications were in limited supply in Russia and that costs had risen, despite the nation generating more of its own treatments.
While prescription pharmaceuticals are free from Western sanctions imposed as a result of the Ukraine conflict, their distribution to Russia has been hampered by transportation, insurance, and customs barriers induced by the conflict and other restrictive measures, according to industry figures.
“There has been a scarcity of certain pharmaceuticals, despite the fact that output of pharmaceutical items increased by roughly 22% in the (first) three quarters of last year,” Putin stated during a televised meeting with authorities.
“Domestic pharmaceuticals account for 60% of all medicines on the market. Nonetheless, a shortage of certain pharmaceuticals has developed, and prices have increased “He went on to say.
Russians hurried to stock up on pharmaceuticals shortly after Russia invaded Ukraine in February last year, with individuals purchasing a month’s worth of medicine in only two weeks.
Russia also imports a major portion of its medical equipment, such as pacemakers and radiation devices, from the European Union and the United States, with the most sophisticated and important gadgets requiring the greatest dependence.